Fuling Technology
001356
KLT
831689
Hand Enterprise Solutions
300170
4
GRANDTECH
835184
5
Doushen(Beijing) Education & Technology Inc.
300010
US Stock MarketDetailed Quotes
NVCT Nuvectis Pharma
- 6.420
- +0.320+5.25%
Close Jan 23 16:00 ET
124.04MMarket Cap-5.53P/E (TTM)
6.700High6.100Low138.32KVolume6.100Open6.100Pre Close890.63KTurnover2.11%Turnover RatioLossP/E (Static)19.32MShares12.10052wk High11.28P/B42.10MFloat Cap4.44052wk Low--Dividend TTM6.56MShs Float20.920Historical High--Div YieldTTM9.84%Amplitude3.080Historical Low6.438Avg Price1Lot Size
About Nuvectis Pharma Company
Nuvectis Pharma, Inc. is a preclinical stage biopharmaceutical company. It focuses on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its product pipeline includes NXP800 and NXP900. The company was founded by Ron Bentsur, Enrique Poradosu and Shay Shemesh on July 27, 2020 and is headquartered in Fort Lee, NJ.
Company Profile
SymbolNVCT
Company NameNuvectis Pharma
Listing DateFeb 4, 2022
Issue Price5.00
Founded2020
CEOMr. Ron Bentsur
MarketNASDAQ
Employees13
Fiscal Year Ends12-31
Address1 Bridge Plaza,Suite 275,2nd floor
CityFort Lee
ProvinceNew Jersey
CountryUnited States of America
Zip Code07024
Phone1-201-614-3151
Websitehttp://nuvectis.com
Company Executives
- Name
- Position
- Salary
- Ron Bentsur
- Chairman of the Board, Chief Executive Officer and President
- 2.69M
- Enrique Poradosu
- Executive Vice President, Chief Scientific and Business Officer
- 1.56M
- Shay Shemesh
- Executive Vice President, Chief Development and Operations Officer
- 1.56M
- Michael J. Carson
- Vice President of Finance, Principal Financial and Accounting Officer
- --
- Matthew L. Kaplan
- Independent Director
- 375.80K
- Kenneth Hoberman
- Independent Director
- 385.80K
- James F. Oliviero, III
- Independent Director
- 385.80K
Trending Stocks
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Stocks & Industries to Watch Under Trump's Second Presidency
Key takeaways Tech stocks underwent substantial growth due to tax cuts and reduced corporate regulations in Trump's first term along with defense and aerospace